Identified over a dozen years ago in the brain and pancreatic islet, β IV -spectrin is critical for the local organization of protein complexes throughout the nervous system. β IV -Spectrin targets ion channels and adapter proteins to axon initial segments and nodes of Ranvier in neurons, and β IV -spectrin dysfunction underlies ataxia and early death in mice. Despite advances in β IV -spectrin research in the nervous system, its role in pancreatic islet biology is unknown. Here, we report that β IV -spectrin serves as a multifunctional structural and signaling platform in the pancreatic islet. We report that β IV -spectrin directly associates with and targets the calcium/calmodulin-dependent protein kinase II (CaMKII) in pancreatic islets. In parallel, β IV -spectrin targets ankyrin-B and the ATP-sensitive potassium channel. Consistent with these findings, β IV -spectrin mutant mice lacking CaMKII-or ankyrin-binding motifs display selective loss of expression and targeting of key protein components, including CaMKIIδ. β IV -Spectrin-targeted CaMKII directly phosphorylates the inwardly-rectifying potassium channel, Kir6.2 (alpha subunit of K ATP channel complex), and we identify the specific residue, Kir6.2 T224, responsible for CaMKII-dependent regulation of K ATP channel function. CaMKII-dependent phosphorylation alters channel regulation resulting in K ATP channel inhibition, a cellular phenotype consistent with aberrant insulin regulation. Finally, we demonstrate aberrant K ATP channel phosphorylation in β IV -spectrin mutant mice. In summary, our findings establish a broader role for β IV -spectrin in regulation of cell membrane excitability in the pancreatic islet, define the pathway for CaMKII local control in pancreatic beta cells, and identify the mechanism for CaMKII-dependent regulation of K ATP channels.
trafficking | local regulation T he coordinate expression, localization, and regulation of ion channels are critical for excitable cell biology, namely, neuronal transmission, cardiac excitation-contraction coupling, endocrine/exocrine secretory regulation, and skeletal muscle function. The spectrin family of polypeptides, originally discovered as a critical component of the erythrocyte plasma membrane over 30 y ago, is now known to play important structural roles in both nonexcitable and excitable cells (1, 2) . Spectrin alpha (α) and beta (β) subunits form antiparallel dimers that self-associate to form tetramers, creating a submembranous scaffolding network anchored to actin filaments via β-spectrin (2). Whereas two genes encode α-spectrin polypeptides (α I -, α II -spectrin), spectrin family diversity is created through assembly of α-spectrin products with five β-spectrin genes (encoding β I -β V -spectrin) (2) . Over a dozen years ago, β IVspectrin was identified in brain and pancreatic islets (3) . Since these findings, a host of studies have identified β IV -spectrin as a critical player for defining local membrane domains in the nervous system (4) (5) (6) . Notably, β IV -spectrin complexes serve essential roles in targeting ankyrin and associated membrane proteins, to axon initial segments and nodes of Ranvier. Dysfunction in β IV -spectrin leads to aberrant membrane protein targeting, cell and animal phenotypes, and early death (6, 7) . Despite these striking findings in brain, the role of β IV -spectrin in pancreatic islets is unknown.
Here, we define a role for β IV -spectrin in regulating membrane excitability in islets. β IV -spectrin directly associates with ankyrin-B and Ca 2+ /calmodulin-dependent protein kinase II (CaMKII). We define the structural requirements for these interactions and show that β IV -spectrin associates with additional islet proteins, including actin and the ATP sensitive potassium channel (K ATP channel). Notably, β IV -spectrin mutant mice that lack ankyrin-or CaMKII-binding activity display coordinate loss of ankyrin, K ATP channel, and CaMKII expression and targeting. Finally, we demonstrate that β IV -spectrin is critical for CaMKII-dependent regulation of the K ATP channel through Kir6.2 residue T224 and show that Kir6.2 T224 phosphorylation is altered in β IV -spectrin mutant mice. In summary, our findings provide initial insight into the role of β IV -spectrin in the expression, targeting, and regulation of critical membrane and signaling proteins in islets.
Results β IV -Spectrin Associates with CaMKII in Pancreas. β IV -Spectrin contains an N-terminal actin-binding domain, a series of 17 spectrin repeats, and a C-terminal domain (Fig. 1A) . The C-terminal domain contains a conserved motif harboring high homology to the autoregulatory domain of Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), a site necessary for CaMKII intramolecular interaction (Fig. 1B) (8) . This motif is present in a handful of CaMKII-associated proteins including the L-type Ca 2+ channel beta subunit (β 2a ) and the NR2B receptor (9) . Given the lack of data on β IV -spectrin function in the islet, we hypothesized that β IVspectrin may function in the pancreas to control CaMKII targeting and expression, similar to observed roles in myocytes (10) .
We confirmed β IV -spectrin mRNA and protein expression in the murine pancreas. Indeed, consistent with the only published data on pancreatic β IV -spectrin (3), β IV -spectrin is found in pancreas (Fig. 1C ) and expressed in islets by immunoblot and immunostaining ( Fig. 1D and Fig. 2A ). In contrast, we observed minimal β IV -spectrin immunostaining in exocrine acinar cells surrounding the islet (Fig. 1D) . Like β IV -spectrin, we observed Significance This study defines a functional role for β IV -spectrin in pancreas, expands the pathways for calcium/calmodulin-dependent protein kinase II (CaMKII) local control in excitable cells, and identifies a mechanism for CaMKII-dependent regulation of K ATP channels. expression of the CaMKII isoform δ within the murine islet ( Fig.  1 E and J) .
We tested a potential β IV -spectrin/CaMKII interaction in pancreas using radiolabeled protein and purified mouse pancreatic islet lysate. β IV -Spectrin directly associates with CaMKIIδ in vitro, determined using a peptide that corresponds to the putative CaMKII-binding motif in the β IV -spectrin C-terminal domain (CTP-P). CTP-P, but not beads alone nor CTP-C (β IVspectrin C-terminal scrambled control peptide), bound radiolabeled CaMKIIδ (Fig. 1H ) and endogenous CaMKIIδ from isolated pancreatic islets or whole pancreas ( Fig. 1 I and J) . Furthermore, β IV -spectrin Ig, but neither control Ig nor beads alone, was able to immunoprecipitate with CaMKIIδ from pancreas and pancreatic islet cell lysates (Figs. 1K and 2A) . Together, these data support a β IV -spectrin/CaMKIIδ interaction in pancreatic islets via a C-terminal domain in β IV -spectrin.
Identification of β IV -Spectrin-and Ankyrin-B-Associated Proteins in Islets. β-Spectrin polypeptides associate with ankyrin proteins through a conserved binding motif in the β-spectrin 15th spectrin repeat (11) . Ankyrin-B (AnkB) is present within the islet and necessary for the targeting and expression of the ATP-sensitive potassium channel (K ATP ) (12) and inositol 1,4,5 trisphosphate (IP3) receptor (13) . Human mutations in Kir6.2 (K ATP channel α-subunit) that block binding with AnkB are associated with neonatal diabetes mellitus (12, 14) , although these variants may also affect K ATP Kir6.2/SUR1 subunit coupling (15) . Consistent with β IV -spectrin localization, AnkB and Kir6.2 are highly Whereas CaMKIIδ associates only with β IV -spectrin fusion constructs containing the distal C-terminal CaMKII binding motif in islet lysates, β IV -spectrin-dependent association with AnkB, Kir6.2, and SUR1 requires residues 1620-2218 (includes 15th spectrin repeat). β IV -Spectrin 1-699 was the only construct to copurify with actin from islet lysates. We observed no interaction of either CaMKIIδ or AnkB with N-terminal GST-β IV -spectrin fusion construct.
expressed in the islet where the K ATP channel regulates cellular excitability and insulin secretion (Fig. 1 F and G) . Moreover, AnkB and β IV -spectrin associate from purified islet lysates by coimmunoprecipitation ( Fig. 2A) . In addition to ankyrin-B, we also observed CaMKIIδ, Kir6.2, and SUR1 (K ATP channel subunit) in β IV -spectrin coimmunoprecipitation experiments ( Fig. 2A ).
Defining the Structural Requirements for β IV -Spectrin Binding for CaMKII and AnkB. We constructed a series of β IV -spectrin GSTfusion proteins containing key regions of the molecule to define the structural requirements for β IV -spectrin association with CaMKII and AnkB (Fig. 2 B and C) . Consistent with peptide pull-down experiments, a β IV -spectrin fusion protein containing the full C terminus (residues 1620-2565) associated with CaMKIIδ from islets ( Fig. 2D and Fig. S1 ). In contrast, fusion proteins lacking the putative CaMKII-association motif (residues 1620-2218 and 2015-2218) did not bind islet CaMKIIδ (Fig. 2D) . We observed no CaMKII-binding activity for a control β IV -spectrin N-terminal fusion protein (residues 1-699; Fig. 2D ). On the other hand, C-terminal β IV -spectrin GST-fusion proteins containing residues 1620-2218 and 1620-2565 displayed robust AnkB-binding activity, whereas truncation of the fusion proximal to spectrin repeat 16 (residues 2015-2218) resulted in loss of AnkB-binding activity (Fig. 2D) . We previously demonstrated that AnkB directly associates with Kir6.2 (12, 16) and AnkB/ SUR1 interactions require Kir6.2 (Fig. S2) . Consistent with these data, C-terminal β IV -spectrin 1620-2218 and 1620-2565 displayed binding activity for Kir6.2 and SUR1, but residues 2015-2218 lacked ability to associate with Kir6.2 or SUR1 (Fig. 2D) . We observed no binding of the β IV -spectrin N terminus to CaMKII, AnkB, Kir6.2, or SUR1; however, as expected, this domain associated with actin (Fig. 2D) . Our results support a model where β IV -spectrin associates with actin, AnkB, and CaMKIIδ through its N terminus, central spectrin repeat domain, and C terminus, respectively. Binding. Nearly 60 y ago, a spontaneous line of "quivering" (qv) mice was identified that displayed severe ataxia, hind-limb paralysis, deafness, and tremor (7) . Subsequent studies identified specific mutations across the murine β IV -spectrin gene, resulting in the qv mouse phenotypes. These in vivo models have proved critical in defining the roles of β IV -spectrin function in physiology and disease (7) . To test the role of β IV -spectrin in islet channel and signaling molecule expression and targeting, we used qv mouse lines harboring mutations that selectively alter AnkB (qv 4J ) and CaMKII association (qv 3J ; Fig. S3A ). We coimmunoprecipitated CaMKIIδ, AnkB, Kir6.2, SUR1, and actin with β IVspectrin from wild-type (WT) mouse islet lysates (Fig. S3B) . Likewise, parallel AnkB Ig coimmunoprecipitations revealed β IV -spectrin, CaMKIIδ, Kir6.2, and SUR1 as AnkB-associated proteins (Fig. S3C) . We observed loss of CaMKIIδ association, but not AnkB, Kir6.2, or SUR1, with β IV -spectrin in islet lysates from the qv 3J mouse lacking spectrin/CaMKII interaction ( Fig.  S3 B and C) ; however, as noted in the next section, CaMKII protein levels are decreased in qv 3J and qv 4J islets, so coimmunoprecipitation inputs were adjusted to compensate for differences in protein expression (SI Materials and Methods). Additionally, CaMKIIδ immunoprecipitated with AnkB Ig in WT, but not qv 3J islets (Fig. S3C) . In qv 4J mice lacking the ankyrin-binding domain, we observed loss of β IV -spectrin association with AnkB, Kir6.2, and SUR1, as well as inability of AnkB to associate with CaMKIIδ ( Fig. S3 B and C) . Finally, AnkB interactions with Kir6.2 and SUR1 were independent of β IV -spectrin or actin as AnkB Ig coimmunoprecipitated both Kir6.2 and SUR1 in qv 4J islet lysates (Fig. S3C) . Based on our data, we hypothesized that β IV -spectrin regulates CaMKII posttranslational expression and targeting. We assessed the requirement of β IV -spectrin for CaMKII expression and targeting in WT, qv 3J , and qv 4J beta cells. As expected, β IVspectrin was expressed throughout the cytosol of WT, qv 3J , and qv 4J beta cells (Fig. 3A) . AnkB expression was present within both WT and qv 3J beta cells, but consistent with the qv 4J mutation lacking ankyrin-binding activity, we observed reduced and diffuse staining of AnkB in qv 4J beta cells (Fig. 3B ). In parallel with its dependence on AnkB for targeting, Kir6.2 (and SUR1) expression (expressed throughout cytosol) was significantly reduced in qv 4J beta cells compared with WT, but not in qv 3J islets (Fig. 3 C and E) . Finally we observed loss of CaMKIIδ expression in both qv 3J and qv 4J beta cells (Fig. 3D) . Immunoblots confirmed significantly reduced CaMKIIδ expression in islet lysates from both qv 3J and qv 4J models (Fig. 3F) . β IV -spectrin may regulate the posttranscriptional stability of CaMKIIδ, as CaMKIIδ mRNA levels were unchanged between WT, qv 3J , and qv 4J mouse islets (Fig. S4) (Fig. 4 B, C , and E). However, cells transfected with Kir6.2 T224A showed no significant decrease in I KATP in the presence of active CaMKII (Fig. 4 D and G) . Notably, when T224 was substituted with a glutamic acid to create a phosphomimetic (Kir6.2 T224E), we observed a significant decrease in K ATP channel current at baseline (compared with WT Kir6.2), even in the absence of CaMKIIδ overexpression (Fig. 4 F 
and G).
To further analyze this site as a potential CaMKII target, we performed in vitro phosphorylation assays on WT and Kir6.2 T224 mutant proteins. Whereas β 2a , a known CaMKII phosphorylation target and WT Kir6.2 were phosphorylated in vitro by CaMKII, Kir6.2-T224A and Kir6.2-T224E showed no significant CaMKII-mediated phosphorylation (Fig. 4H) . Together, these data strongly support the role of CaMKII direct phosphorylation, demonstrate that this phosphorylation is at least in part direct, and implicate Kir6.2 T224 as a CaMKII target site in this pathway.
CaMKII Regulates Kir6.2 by Phosphorylation of Kir6.2 T224. We created an affinity-purified phospho-specific antibody against Kir6.2 pT224 to evaluate the role of the β IV -spectrin/CaMKII pathway for K ATP regulation in pancreas. The specificity of the antibody for the Kir6.2 pT224 site was confirmed by immunoblots that detected GFP-Kir6.2 from transfected cells, but not Kir6.2 T224A or Kir6.2 T224E (Fig. S5) .
We evaluated Kir6.2 pT224 Ig in INS-1 cells, a rat insulinoma cell line commonly used to evaluate Kir6.2 and insulin secretion. Cells were analyzed for Kir6.2 pT224 ± isoproterenol (1 μM) to stimulate CaMKII activity. Notably, we observed nearly a fourfold increase in Kir6.2 pT224 [and twofold increase in activated CaMKII (CaMKII pT286)] in isoproterenol (Iso)-treated cells compared with untreated cells, whereas we observed no difference in total Kir6.2 or SUR1 levels ( Fig. 5 A and B) . To determine whether this activation required CaMKII, we performed parallel experiments in the presence of the CaMKII inhibitor, autocamtide-2-related inhibitory peptide (AIP). In support of a role of CaMKII in regulation of Kir6.2 pT224, AIP blocked both CaMKII pT286 and Kir6.2 pT224 activation ( Fig. 5 A and B) .
Consistent with (i) a role for β IV -spectrin in CaMKII regulation and (ii) a role for CaMKII in the direct regulation of Kir6.2 in vivo T224, Kir6.2 pT224 associated with β IV -spectrin and AnkB in coimmunoprecipitation experiments from WT, but not qv 3J or qv 4J , pancreatic islet lysates ( Fig. 5 C and D) . Further, we observed decreased levels of Kir6.2 pT224 in qv 3J and qv 4J pancreatic islet lysates (Fig. 5 E and F) compared with WT islets. In agreement with immunostaining data, we observed decreased Kir6.2 and SUR1 levels in qv 4J , but not qv 3J islets (Fig. 5 E and  F) . Finally, staining of pancreatic islets revealed similar results, namely, a significant decrease in Kir6.2 pT224 expression in islets from qv 3J mice compared with WT mice (Fig. S6) . These data support the hypothesis that β IV -spectrin is critical for the regulation of K ATP channel activity through direct CaMKII phosphorylation of Kir6.2.
Discussion
The K ATP channel is a vital component in the regulation of insulin secretion, with mutations resulting in diabetes mellitus or hyperinsulinemia (18) . However, little progress has been made regarding the posttranslational modification of the K ATP channel. β IV -spectrin is a multifunctional regulatory protein for K ATP channels in the islet. Using mutant β IV -spectrin mouse models, we determined that β IV -spectrin is necessary for the expression and targeting of select structural and regulatory proteins in the islet. For example, our data show that β IV -spectrin is critical for expression of the CaMKIIδ polypeptide in islets. Thus, β IVspectrin fails to coimmunoprecipitate with CaMKIIδ in qv 3J islets (Fig. S3 ) due to both its inability to associate with CaMKIIδ ( Fig.  2 C and D) and the reduced steady-state levels of CaMKIIδ polypeptide in the qv 3J lysate (Fig. 3) . Additionally, we identified a regulatory mechanism for K ATP channels: direct phosphorylation of Kir6.2 T224 by CaMKII. Specifically, Kir6.2 T224 phosphorylation results in a significant decrease in I KATP. Finally, using an antibody that specifically recognizes the phosphorylated form of Kir6.2 T224, we demonstrated that qv 3J and qv 4J islets lack phosphorylated Kir6.2 T224, as well as CaMKIIδ. Collectively, our data define CaMKII as a membrane skeleton component in the pancreatic islet and β IV -spectrin/AnkB as a necessary molecular platform for K ATP channel regulation. As discussed below, future experiments to evaluate Kir6.2 T224 phosphorylation status in human and animal models of diabetes/metabolic disease will be important to assess the potential of this target site as a biomarker in the early progression of disease. Further, whereas our data demonstrate that β IV -spectrin associates with CaMKII, ankyrin-B, actin, Kir6.2, and SUR1 in islets, these results do not necessarily support that these proteins reside in a single macromolecular complex. Future experiments to validate a single macromolecular complex would include expanded coimmunoprecipitation studies that (i) verify that antibodies against each of the proteins in the putative complex recovers each of the other components and (ii) demonstrate that recovery of one of the components of the putative complex is prevented in the absence of one of the other molecules.
Whereas this study addresses the specific role of Kir6.2/SUR1 in the islet, K ATP channels are widely distributed in the central and peripheral nervous system, pituitary, cardiac muscle, smooth muscle, and skeletal muscle (18, 19) where they regulate such diverse physiological functions as neuronal excitability, hormone are significantly decreased in qv 3J and qv 4J islet lysates (n = 4 mice, P < 0.05), whereas CaMKIIδ mRNA levels are unchanged (Fig. S4) .
secretion, vascular tone, heart rate, and protection of cells against metabolic stress (18) . Notably, human KCNJ11 gene variants result in developmental delay, epilepsy, and neonatal diabetes (DEND) due to overactive K ATP channels in muscle, peripheral nerves, and brain. In heart, K ATP channels serve a protective role by activating under metabolic stress and leading to a shortening of the action potential. To this end, K ATP channels serve as protectors against cardiac maladaptation to stress, as indicated by hearts deficient in K ATP channels being more susceptible to Ca 2+ -dependent maladaptive remodeling, progressing to organ failure and death. Whereas KCNJ11 polymorphisms have been associated with cardiac disease, no clear gene mutations have been directly linked with severe forms of arrhythmia or myopathy to date.
In addition to regulation by intracellular nucleotides, K ATP channel activity, and consequently its physiological function, can be modified by protein phosphorylation. For example, CaMKII activity has been linked with K ATP channel regulation in heart and brain (17, 20) . K ATP channels are also modulated by cAMPdependent protein kinase (PKA) (21) , Ca 2+ /phospholipiddependent protein kinase (PKC) (22) , extracellular signal-regulated kinase (ERK) (23) , and cGMP-dependent protein kinase (PKG) (24) . Prior work from Jan and coworkers identified Kir6.2 T224 as a site for PKA-dependent phosphorylation in HEK293 cells (25) . Likely, both CaMKII and PKA will have functional roles on Kir6.2 regulation in vivo, although our data demonstrate that CaMKII inhibition is sufficient to ameliorate Kir6.2 pT224 phosphorylation in isoproterenol-treated INS1 cells.
Whereas our findings identify β IV -spectrin as a component in the regulation of K ATP channel activity in the islet, they also raise many questions regarding the specific role of CaMKII-mediated phosphorylation. There is a growing body of evidence from enzyme activation studies in support of a role for CaMKII in insulin secretion. Specifically, there is a correlation between CaMKII activation with glucose-stimulated insulin secretion in rat islets (26) . CaMKII activation in the beta cell has been linked to phosphorylation of proteins that are involved in secretory events, namely, microtubule-associated protein-2 and synapsin I. Whereas the phosphorylation of proteins involved in granule exocytosis has been identified, little work has been performed to define a role for CaMKII in the regulation of beta cell ion channel function. Previous studies have demonstrated that suppression of cardiac CaMKII, via the transgenic expression of a CaMKII inhibitor, results in an augmentation of K ATP -dependent current (17) . We have found that expression of an active form of CaMKII produces a significant decrease in I KATP in a heterologous expression system, suggesting that CaMKII-mediated phosphorylation of the K ATP channel results in a decrease in (17) . Future studies to discern specific consequences of CaMKIImediated K ATP channel phosphorylation (i.e., single channel kinetics, ATP sensitivity, and/or plasma membrane density/stability) will be important to provide insight into the specific roles of CaMKII in beta cell K ATP channel modulation and potential regulation of insulin secretion. As noted above, CaMKII-mediated phosphorylation of the K ATP channel results in a decrease in I KATP , therefore we hypothesize CaMKII activation to decrease glucose-stimulated insulin secretion. Considering that previous studies have shown a direct relationship between the activation of pancreatic CaMKII and glucose-stimulated insulin secretion, it will be important to eventually evaluate glucosestimulated insulin secretion in qv 3J and qv 4J mice that have disrupted β IV -spectrin-mediated CaMKII expression and localization. However, for these studies, it will be important to consider the inherent physiological differences for insulin regulation in mice vs. humans (i.e., Kir6.2 null mice do not display hypoglycemia, but display increased insulin sensitivity and low insulin levels). It will be interesting to evaluate the effect of CaMKII inhibition on K ATP channel ATP sensitivity, which represents a critical factor in K ATP channel regulation. Second, what is the localization of K ATP channel populations targeted by CaMKII? Whereas we and others have observed Kir6.2 and SUR1 across the beta cell (immunostaining throughout cytosol and membrane, Figs. 1 and 3) , K ATP channel subunits have also been observed at the insulin granule (27) . Compared with the HEK cell or cardiomyocyte, the pancreatic beta cell is small with few well-defined membrane features. Therefore, future experiments using high-resolution double immunogold labeling of the beta cell for CaMKII and K ATP channel subunits will be necessary to resolve this issue. In fact, beyond CaMKII and K ATP channel subunits, our data demonstrate multiple heterogeneous subpopulations of spectrin and ankyrin in beta cells (with or without colocalization with insulin). It will be interesting for future studies to define the specific localization, molecular identities, and functions of these subpopulations.
In summary, our findings demonstrate a role for β IV -spectrin in the targeting and expression of CaMKII in the pancreatic islet. Further, the direct coupling of β IV -spectrin to AnkB potentially localizes K ATP channel subunits in immediate proximity with CaMKII for direct Kir6.2 phosphorylation (Kir6.2 T224). We predict that these proteins play key roles in vertebrate excitable cell physiology, although this regulation is likely complex. For example, we previously demonstrated that a human Kir6.2 E322K permanent neonatal diabetes mutation that blocks AnkB association is associated with both defects in membrane trafficking and Kir6.2 membrane biophysical activity (12) . However, Tarasov et al. found that this site may also be involved in coupling Kir6.2 regulation with SUR1 (15) , and individuals with the KCNJ11 E322K mutation respond to sulfonylurea treatment. Whereas additional data will be necessary to define the mechanisms underlying the regulation of these proteins at baseline and in disease, these findings ultimately support the clear in vivo roles of the cytoskeleton and cytoskeletal-associated proteins in the regulation of excitable cell function.
Materials and Methods
Kir6.2 mutants (S37A, S37E, T224A, T224E, S372A, and S372E) were generated using the Stratagene QuikChange site-directed mutagenesis kit, manufacturer's protocols, and unique primers.
Additional materials and methods are found in SI Materials and Methods.
